![]() |
市场调查报告书
商品编码
1666940
谷胱甘肽市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测Glutathione Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球谷胱甘肽市场价值为 2.529 亿美元,预计 2025 年至 2034 年期间的复合年增长率为 6.8%。谷胱甘肽广泛用于药物、化妆品和膳食补充剂,由于其具有中和自由基和支持整体健康的能力,其需求正在上升。
在製药领域,谷胱甘肽在解决与解毒、氧化压力和老化相关的健康问题方面发挥关键作用。其在医疗保健领域的不断扩展的应用极大地促进了其市场的成长。化妆品产业也利用谷胱甘肽对皮肤健康的有益作用,推动对美容和护肤产品的需求。此外,将其作为免疫增强剂添加到膳食补充剂中引起了注重健康的消费者的兴趣,进一步刺激了市场需求。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 2.529 亿美元 |
预测值 | 4.887 亿美元 |
复合年增长率 | 6.8% |
还原谷胱甘肽 (GSH) 部分在 2024 年占据市场主导地位,营收达 1.621 亿美元。这种形式的谷胱甘肽以其优越的生物利用度和有效性而闻名,使其成为各种应用中的首选。作为一种强大的抗氧化剂,GSH 在解毒、免疫系统支持和对抗氧化压力方面发挥着至关重要的作用。它在医疗保健、美容和保健领域的突出地位凸显了其日益增长的重要性,而生产技术的进步不断提高其可及性。
医药应用仍是谷胱甘肽市场的主要驱动力,2024 年市场规模达 1.142 亿美元。正在进行的研究和创新为其利用开闢了新的途径,巩固了其作为医疗重要成分的地位。
美国谷胱甘肽市场价值在 2024 年将达到 7,120 万美元,预计到 2034 年将以 7.1% 的复合年增长率增长。谷胱甘肽在健康和个人护理领域的应用日益广泛,再加上研究和生物技术的进步,进一步增强了美国市场的前景
The Global Glutathione Market was valued at USD 252.9 million in 2024 and is projected to grow at a CAGR of 6.8% between 2025 and 2034. This growth is primarily fueled by the increasing awareness of glutathione's antioxidant properties and its health-enhancing benefits. Widely used in pharmaceuticals, cosmetics, and dietary supplements, glutathione's demand is on the rise due to its ability to neutralize free radicals and support overall well-being.
In the pharmaceutical sector, glutathione plays a critical role in addressing health issues related to detoxification, oxidative stress, and aging. Its expanding application in healthcare has significantly contributed to its market growth. The cosmetic industry also leverages glutathione for its beneficial effects on skin health, driving demand for beauty and skincare products. Additionally, its inclusion in dietary supplements as an immunity booster has captured the interest of health-conscious consumers, further bolstering market demand.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $252.9 Million |
Forecast Value | $488.7 Million |
CAGR | 6.8% |
The reduced glutathione (GSH) segment dominated the market in 2024, accounting for USD 162.1 million in revenue. This form of glutathione is known for its superior bioavailability and effectiveness, making it a preferred choice across various applications. As a powerful antioxidant, GSH plays an essential role in detoxification, immune system support, and combating oxidative stress. Its prominence in the healthcare, beauty, and wellness sectors underscores its growing importance, while advancements in production techniques continue to enhance its accessibility.
Pharmaceutical applications remain a key driver of the glutathione market, generating USD 114.2 million in 2024. The use of glutathione in therapeutic formulations, particularly for addressing oxidative damage and detoxification, highlights its critical role in healthcare. Ongoing research and innovation are opening new avenues for its utilization, reinforcing its status as a vital ingredient in medical treatments.
The U.S. glutathione market, valued at USD 71.2 million in 2024, is expected to grow at a CAGR of 7.1% through 2034. The robust healthcare infrastructure and increasing consumer interest in health-promoting products are fueling growth in this region. The rising use of glutathione in wellness and personal care, combined with advancements in research and biotechnology, further strengthens the market's outlook in the U.S.